Chairpersons: Catharina Boehme, FIND, and Daniela Cirillo, San Raffaele Scientific Institute, NDWG Co-Chairs
Introduction
Strategic framework for new diagnostics 2016-2020: Progress towards Global Plan goals
Catharina Boehme, FIND, NDWG Co-Chair
Presentations and audio for each session:
Part I - Supporting TB elimination: Advances towards delivering new diagnostics for latent tuberculosis infection (LTBI)
- Setting the scene for LTBI diagnostics
Alberto Matteelli, University of Brescia, Coordinator NDWG Task Force on LTBI and tests of progression
Presentation, Audio - The evolving concept of LTBI diagnosis: Tests for incipient TB and tests for persistent infection
Frank Cobelens, KNCV and AIGHD
Presentation, Audio - Target product profile for a test for incipient TB: Making better predictions to improve patient care
Samuel Schumacher, FIND
Presentation, Audio - Guidance document for the evaluation of TB prediction tests to inform WHO endorsement - An update
Frank Cobelens, KNCV and AIGHD
Presentation, Audio - Q&A and discussion
Audio
Part II - Next Generation Sequencing for improved management of patients with drug resistant TB
- Grading of mutations associated with drug resistance and their use in clinical practice
Daniela Cirillo, San Raffaele Scientific Institute
Presentation, Audio - Optimising patient care with existing molecular screening tests in high-burden countries
Camilla Rodrigues, Hinduja Hospital
Presentation - Deeplex-MycTB, an all-in-one test for diagnosis and surveillance of drug-resistant TB
Philip Supply, French National Center for Scientific Research and Genoscreen
Presentation, Audio
Part III - Advancing biomarker discovery for TB point-of-care tests
- The biomarker pipeline for active TB detection
Tobias Broger, FIND, Coordinator NDWG Task Force on Biomarkers for TB point-of-care tests
Presentation, Audio - Biomarkers for paediatric TB and update on standardized SOPs for pediatric sample collection
Rinn Song, Boston Children’s Hospital/Harvard Medical School
Presentation, Audio